gracecast-085_lung-cancer_alk inhibition: who to screen and options for alk-positive patients
Published 12 years ago • 494 plays • Length 26:56Download video MP4
Download video MP3
Similar videos
-
17:30
gracecast-084_lung-cancer_alk inhibition: science and early clinical experience by dr. ben solomon
-
3:44
alk inhibitors for acquired resistance: zykadia and alectinib
-
5:42
gracecast - lcvl- what are the options after a patient with an alk-positive advanced nsclc develops
-
19:47
alk positive forum next generation inhibitors
-
37:41
gracecast-044_lung-cancer_camidge on alk inhibitors
-
4:58
how do the new alk inhibitor drugs compare to xalkori (crizotinib) for alk lung cancer patients?
-
21:58
grace targeted therapies lung cancer 2021 - alk therapies-which one comes first, how do we sequence?
-
5:52
alk positive forum disease progression xalkori
-
4:27
alk positive lung cancer forum: xalkori
-
23:44
2020 ttf alk session raez sequence of alk inhibitors
-
10:37
gracecast-141_lung_highlights in lung cancer, 2012: alk inhibitors for patients with alk or ros1
-
2:52
understanding acquired resistance in alk lung cancer
-
12:46
gracecast-086_lung-cancer_q&a with drs. solomon and camidge on alk inhibition for advanced nsclc
-
4:14
should a second generation alk inhibitor be first line therapy for patients with alk-positive nsclc?
-
33:47
gracecast-049_lung-cancer_weiss on egfr therapy for early stage nsclc
-
1:47
alk rearrangements: what are they, and who has them?
-
7:41
gracecast - lcvl - h. jack west md - can alk inhibitors treat and prevent brain metastases
-
2:00
ceritinib and other second generation alk inhibitors for acquired resistance in alk-positive nsclc
-
25:07
gracecast-101_lung-cancer_mm in lc pt6: dr. goss on incorporating markers across a hc system